Willow Lane Acquisition Corp. (NASDAQ:WLACU) announced the pricing of its $110 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “WLACU”, Friday, November 8, 2024.
The new SPAC intends to conduct a broad search to find an established middle market company valued at about $1 billion or less.
The Company’s management team is led by B. Luke Weil, its Chief Executive Officer and Chairman of the Board of Directors of the Company (the “Board”), George Peng, Chief Financial Officer, and Marjorie (Maya) Hernandez, Treasurer and Director of Business Development. In addition, the Board includes Robert Stevens, Rayne Steinberg, and Mauricio Orellana. A. Lorne Weil serves as Special Advisor to the Company.
Total SPAC deal count for 2024 year-to-date is now 45. This offering is expected to close on Monday, November 11, 2024.
BTIG, LLC is acting as sole book-running manager for the offering. Craig-Hallum Capital Group LLC is acting as co-manager for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...